Clinical study on the radiosensitizer of esophageal carcinoma

Abstract

Kang Mei, Quan Xunfeng. Clinical study on the radiosensitizer of esophageal carcinoma[J]. Journal of International Oncology, 2015, 42(12): 932-935.

［1］ Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics［J］. CA Cancer J Clin, 2012, 62(4): 220-241. ［2］ Siegel R, Naishadham D, Jemal A, et al. Cancer statistics, 2013［J］. CA Cancer J Clin, 2013, 63(1): 11-30. ［3］ Ma DY, Tan BX, Liu M, et al. Concurrent threedimensional conformal radiotherapy and chemotherapy for postoperative recurrence of mediastinal lymph node metastases in patients with esophageal squamous cell carcinoma: a phase 2 singleinstitution study［J］. Radiat Oncol， 2014, 9: 28. ［4］刘宗展. 奈达铂增敏放疗与单纯放疗治疗50例食管癌的疗效对比分析［J］. 中国医药指南, 2013, 5(15): 34-36. ［5］ Kim YJ, Lee WJ, Woo SM, et al． Comparison of capecitabine and 5fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer［J］. Radiat Oncol, 2013, 8(8): 160-163. ［6］ Uehara K, Hiramatsu K, Maeda A, et al. Neoadjuvant oxaliplatin and capecitabine and bevacizumab without radiotherapy for poorrisk rectal cancer: NSOG 03 phase Ⅱ trial［J］． Jpn J Clin Oncol, 2013， 43(10): 964-971. ［7］ Shen ZH, Wu XH, Li B, et al. Nedaplatin concurrent with threedimensional conformal radiotherapy for treatment of locally advanced esophageal carcinoma［J］. World J Gastroenterol, 2013, 19(48): 9447-9952. ［8］ Zeng YC, Wu R, Xu ZG, et al． Safety and radiationenhancing effect of sodium glycididazole in locoregionally advanced laryngeal cancers previously treated with platinumcontaining chemotherapy regimens:a preliminary report［J］. Cancer Radiother, 2010, 14(1): 59-64. ［9］王明智, 吴伟, 吴刚, 等. 甘氨双唑钠对食管癌放疗增敏作用的临床观察［J］. 中国现代医药杂志, 2011, 13（10）: 63-65. ［10］秦尚斌, 王雅棣, 杨俊泉, 等. 甘氨双唑钠胸段食管鳞癌放射增敏作用——Ⅲ期多中心随机对照研究［J］. 中华放射肿瘤学杂志, 2012,13(10): 426-429．［11］米登海, 任维维, 田金徽, 等. 甘氨双唑钠对食管癌放射治疗增敏作用的Meta分析［J］. 中国循证医学杂志, 2012, 12(9): 1122-1128. ［12］ Cui C, Mao L, Chi Z, et al. A phase Ⅱ, randomized doubleblind,placebocontrolled multicenter trial of endostar in patients with metastic melanoma［J］. Mol Ther, 2013, 21(7): 1456-1463. ［13］ Jiang XD, Dai P, Wu J, et al. Effect of recombinant human endostatin on radiosensitivity in patients with nonsmallcell lung cancer［J］. Int J Radiation Oncol Biol Phys, 2012, 83(4): 1272-1277. ［14］ McGee MC, Hamner JB, Williams RF, et al. Impmved intmtumoral oxygenaltion through vascular normalizetion increase glioma sensitivity to ionizing radiation［J］. Int J Radiat Oncol Biol Phys, 2010, 76(5): 1537-1545. ［15］胜世杰, 孙静, 冯连杰. 恩度联合三维适形放疗治疗老年晚期食管癌临床观察［J］．肿瘤基础与临床, 2010, 23(2): 149-150．［16］王春英, 程明. 尼妥珠单抗联合三维适形放疗治疗根治性放疗后复发食管癌的疗效分析［J］. 中国药物与临床, 2013, 13(4): 504-505. ［17］ Ruhstaller T, Hess M, Dietrich D. et a1. Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable,locally advanced esophageal carcinoma:a prospective．multicenter phase ⅠB/Ⅱ Trial(SAKK 75/06)［J］. J Clin Oncol, 201l, 29(6): 626-631. ［18］ Amato E, Italiano A, Leotta S, et al. Monte Carlo study of the dose enhuancement effect of gold nanoparticles duringn Xray therapies and evaluation and evaluation of the antiangiogenic effect on tumour capillary vessels［J］. J Xray Sci Technol, 2013, 21(2): 237-247. ［19］ Hainfeld JF， Dilmanian FA, Zhong Z, et al. Gold nanopartiecles enhance the radiation therapy of a murine squamous cell carcinoma［J］. Phys Med Biol, 2010, 55(11): 3045-3059. ［20］ Jeremic B, Aguerri AR, Filipovic N. Radiosensitization by gold nanoparticles［J］. Clin Transl Oncol, 2013, 15(8): 593-601. ［21］ Qiao Q, Jiang Y, Li G. Curcumin improves the antitumor effect of Xray irradiation by blocking the NKkappaB pathway:an invitro study of lymphoma［J］. Anticancer Drugs, 2012, 23(6): 597-605. ［22］吴宏, 闫国成, 王双全, 等. 姜黄素对胃癌细胞放疗增敏作用的研究［J］. 陕西医学杂志, 2014, 43(2): 137-139. ［23］ Chiu HW, Lin JH, Chen YA, et al. Combination treatment with arsenic trioxide and irradiation enhances cellkilling effects in human fibrosarcoma cells in vitro and through induction of both autophagy and apoptosis［J］． Autophagy, 2010, 6(3): 353-365. ［24］景绍武, 王雅棣, 吴凤鹏, 等. 三氧化二砷对食管癌细胞株Eca109的放射增敏作用及机制［J］. 肿瘤防治研究, 2011, 38(6): 620-623. ［25］ Blattmann C, Thiemann M, Stenzinger A, et al. Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model［J］. Strahlenther Onkol, 2013, 189(11): 957-966. ［26］ Chen X, Wong P, Radany E, et al. HDAC inhibitor, valproic acid,induces p53dependent radiosensitization of colon cancer cells［J］. Cancer Biother Radiopharm, 2009, 24(6): 689-699. ［27］ Dong M, Ning ZQ, Xing PY, et al. Phase Ⅰ study of chidamide(CS055/HBI8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas［J］. Cancer Chemother Pharmacol, 2012, 69(6): 1413-1422. ［28］葛宜枝, 汪步海, 徐立春. 肿瘤坏死因子α的放疗增敏机制［J］. 国际肿瘤学杂志, 2015, 42(1): 49-51. ［29］ Dumont FJ, Bischoff P. Disrupting the mTOR signaling network as a potential strategy for the enhancement of cancer radiotherapy［J］. Curr Cancer Drug Targets, 2012, 12(8): 899-924.

[1]	Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma： a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[4]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[5]	Wan Fang, Yang Gang, Li Rui, Wan Qijing.Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer[J]. Journal of International Oncology, 2024, 51(4): 204-209.
[6]	Qian Xiaotao, Shi Ziyi, Hu Ge.A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(3): 151-156.
[7]	Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.Progress of radiotherapy in oligometastatic non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 170-174.
[8]	Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients[J]. Journal of International Oncology, 2024, 51(1): 37-42.
[9]	Cui Tenglu, Lyu lu, Sun Pengfei.Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2023, 50(9): 548-552.
[10]	Shandong Medical Association Multidisciplinary Joint Committee on Lung Cancer.Shandong Provincial Medical Association multidisciplinary standardized diagnosis and treatment guidelines for esophageal carcinoma （2023 Edition）[J]. Journal of International Oncology, 2023, 50(7): 385-397.
[11]	Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.Research progress on the application of combining radiotherapy and systemic therapy in breast cancer[J]. Journal of International Oncology, 2023, 50(6): 362-367.
[12]	Lyu Lu, Sun Pengfei.Gut flora and cervical cancer[J]. Journal of International Oncology, 2023, 50(6): 373-376.
[13]	Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association, Radiation Oncology Therapy Branch, Chinese Medical Association, Chinese Association of Radiation Therapy, China Anti-Cancer Association.Chinese experts' consensus on the application of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy （2023 version）[J]. Journal of International Oncology, 2023, 50(4): 193-201.
[14]	Xu Meng, Jiang Wei, Zhu Haitao, Cao Xiongfeng.Research progress of cancer-associated fibroblasts in tumor radiotherapy resistance[J]. Journal of International Oncology, 2023, 50(4): 227-230.
[15]	Shi Xaioqi, Wang Hongyan.Research progress on the interaction between gut microbiota and radiation enteritis[J]. Journal of International Oncology, 2023, 50(4): 244-247.

Clinical study on the radiosensitizer of esophageal carcinoma

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments